Immunovant, Inc. (IMVT) vs Ligand Pharmaceuticals Incorporated (LGND)

Immunovant, Inc. and Ligand Pharmaceuticals Incorporated are both Biotechnology companies. Immunovant, Inc. is the larger, with a market value of $7.1B against $6.1B — 1.2× the size. Immunovant, Inc. has negative trailing earnings, so its P/E is not meaningful; Ligand Pharmaceuticals Incorporated trades at 30.1×. Ligand Pharmaceuticals Incorporated has the higher net margin (67.9% vs 0.00%) and the higher return on invested capital (8.19% vs 0.00%). Across the 14 metrics below, Ligand Pharmaceuticals Incorporated leads on 13 and Immunovant, Inc. on 1.